Cannabidiol could support antibiotics and boost their effectiveness

Lately, medical researchers around the world have shown that if the trend of overusing antibiotics continues, we could see an increase in the bacteria resistance to them. That will diminish the effectiveness of treatments in many patients. Nevertheless, recent studies have proven that, when used in conjunction with antibiotics, Cannabidiol (CBD) could become a real alternative.

Since Sir Alexander Fleming discovered penicillin in 1928, antibiotics have saved millions of people from fatal infections worldwide. However, over time, bacteria have developed mechanisms to avoid the effects of antibiotics and become resistant to them. Because of that, scientists are looking to alternatives that could be used together with current medicines in treatment, or which could serve as a building block to new breakthroughs.

Recent research studies have proven that Cannabidiol (CBD), one of the many chemical compounds extracted from the Cannabis Sativa, could be used as a natural remedy for many common ailments. This makes Cannabidiol (CBD) a potential option for the development of new medicines.

If you want to know more about the many benefits of cannabis, how it could change the medical landscape in the near future and to find out the latest cannabis news, download the Hemp.im mobile application.

Cannabidiol (CBD) as a possible antibiotic for future treatments

One of the compounds researchers think it could support the antibiotic effect is cannabidiol (CBD), which is a cannabinoid derived from hemp. One of the research teams from the University of Southern Denmark has published a scientific study confirming that indeed cannabidiol (CBD) enhances the antibiotic effect of antibiotics when used together.

“When we combined cannabidiol (CBD) and antibiotics in medical treatment, we saw a stronger effect than when patients were treated only with antibiotics. So, in order to kill a certain number of bacteria, we needed fewer antibiotics,” described the research author Janne Kudsk Klitgaard.

In the study, cannabidiol (CBD) was used to enhance the effect of the bacitracin antibiotic on Staphylococcus Aureus bacteria, a pathogen that is usually acquired in a hospital, and which is responsible for many diseases. Also, it is estimated that 10 to 50% of the population is constantly or periodically carrying these bacteria without any symptoms of the disease.

Cannabidiol (CBD) and antibiotics show remarkable results when used together

According to scientists, the combination of cannabidiol (CBD) and antibiotics may be a new revolutionary way of treating infections with antibiotic-resistant bacteria. When the researchers treated Staphylococcus aureus bacteria with a combination of cannabidiol (CBD) and antibiotic, three things happened:

The bacteria could no longer reproduce normally
The expression of some key genes (cell division and autolysis genes) in bacteria was reduced
The bacterial membrane became unstable

According to some scientists, currently, the overuse of antibiotics in modern society is the main cause of antibiotic resistance. However, if we combine an antibiotic with an auxiliary compound that enhances the effect of the antibiotic, then less antibiotic is needed to achieve the same effect. Janne Kudsk Klitgaard claimed that cannabidiol (CBD) can not only help in the fight against Staphylococcus aureus bacteria but can also contribute to weakening their resistance to antibiotics.

All these results could lead to new breakthroughs in the near future, giving medics a new and unexpected tool in their arsenal against bacteria. In addition, if CBD is proven to weaken bacteria resistance to antibiotics by a big margin, it could extend the lifespan and effectiveness of current antibiotics, giving the population a big relief for years to come.

(Featured image by Volodymyr Hryshchenko on Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Hemp.im, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in FAKTY KONOPNE.PL, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Daphne Freeman

Daphne Freeman has worked in the crowdfunding and impact investing industry for the past few years, gaining experience in marketing, and connecting businesses and entrepreneurs in need with the right investors. As a seasoned grant writer as well as financial market journalist, she is passionate about making a social impact in the world. A free spirit, Daphne also enjoys writing and exploring topics of interest, currently CBD, health and beauty, and social media influencers.